Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifies LRRC4C, LHX5-AS1 and nominates ancestry-specific loci PTPRK, GRB14, and KIAA0825 as novel risk loci for Alzheimer’s disease: the Alzheimer’s Disease Genetics Consortium

ABSTRACT
Limited ancestral diversity has impaired our ability to detect risk variants more prevalent in non-European ancestry groups in genome-wide association studies (GWAS). We constructed and analyzed a multi-ancestry GWAS dataset in the Alzheimer’s Disease (AD) Genetics Consortium (ADGC) to test for novel shared and ancestry-specific AD susceptibility loci and evaluate underlying genetic architecture in 37,382 non-Hispanic White (NHW), 6,728 African American, 8,899 Hispanic (HIS), and 3,232 East Asian individuals, performing within-ancestry fixed-effects meta-analysis followed by a cross-ancestry random-effects meta-analysis. We identified 13 loci with cross-ancestry associations including known loci at/near CR1, BIN1, TREM2, CD2AP, PTK2B, CLU, SHARPIN, MS4A6A, PICALM, ABCA7, APOE and two novel loci not previously reported at 11p12 (LRRC4C) and 12q24.13 (LHX5-AS1). Reflecting the power of diverse ancestry in GWAS, we observed the SHARPIN locus using 7.1% the sample size of the original discovering single-ancestry GWAS (n=788,989). We additionally identified three GWS ancestry-specific loci at/near (PTPRK (P=2.4×10-8) and GRB14 (P=1.7×10-8) in HIS), and KIAA0825 (P=2.9×10-8 in NHW). Pathway analysis implicated multiple amyloid regulation pathways (strongest with Padjusted=1.6×10-4) and the classical complement pathway (Padjusted=1.3×10-3). Genes at/near our novel loci have known roles in neuronal development (LRRC4C, LHX5-AS1, and PTPRK) and insulin receptor activity regulation (GRB14). These findings provide compelling support for using traditionally-underrepresented populations for gene discovery, even with smaller sample sizes.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
National Institute of Aging
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Written consent was obtained from all participants and study protocols were approved by the University of Pennsylvania Institutional Review Board.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Data Availability: Data are available through the National Institute on Aging Genetics of Alzheimer Disease Data Storage Site (NIAGADS) Data Sharing Service (DSS)
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
0
Author Videos
- Addiction Medicine (418)
- Allergy and Immunology (740)
- Anesthesia (217)
- Cardiovascular Medicine (3180)
- Dermatology (268)
- Emergency Medicine (469)
- Epidemiology (13156)
- Forensic Medicine (18)
- Gastroenterology (879)
- Genetic and Genomic Medicine (4988)
- Geriatric Medicine (458)
- Health Economics (764)
- Health Informatics (3143)
- Health Policy (1115)
- Hematology (418)
- HIV/AIDS (988)
- Medical Education (463)
- Medical Ethics (122)
- Nephrology (512)
- Neurology (4736)
- Nursing (252)
- Nutrition (701)
- Oncology (2437)
- Ophthalmology (692)
- Orthopedics (272)
- Otolaryngology (335)
- Pain Medicine (316)
- Palliative Medicine (88)
- Pathology (524)
- Pediatrics (1265)
- Primary Care Research (539)
- Public and Global Health (7301)
- Radiology and Imaging (1641)
- Respiratory Medicine (954)
- Rheumatology (468)
- Sports Medicine (411)
- Surgery (528)
- Toxicology (66)
- Transplantation (226)
- Urology (196)